PRESS-RELEASE ·Filed Apr 29, 2026
Press release: earnings
Actionable Insight • Neutral
Monitor the actual Q1 2026 earnings release on May 6 for updated financials and pipeline progress. No immediate trading action needed based on this filing alone.
Final — all horizons settled through T+60d
TSHA ▼ -11.96% at T+60d
NEUTRAL call ✗ call lost -11.96% · α vs SPY -16.07% · entry $6.27 → $5.52
T+1d
+1.91%
call +1.91% · α +0.89%
$6.39
settled 5mo ago
T+5d
+10.69%
call +10.69% · α +7.58%
$6.94
settled 5mo ago
T+20d
-8.29%
call -8.29% · α -13.75%
$5.75
settled 4mo ago
T+60d
-11.96%
call -11.96% · α -16.07%
$5.52
settled 2mo ago
Price Chart
Loading chart...
Executive Summary
Taysha Gene Therapies announced the date for its Q1 2026 earnings report and conference call on May 6, 2026. This is a routine scheduling event with no material financial information disclosed.
Key Facts
- Taysha will report Q1 2026 financial results on May 6, 2026 before market open.
- Conference call scheduled for 8:30 AM ET on the same day.
- No preliminary financial results or guidance were provided in this announcement.
Financial Impact
No financial impact from this filing; event is purely administrative.
Risk Factors
- Routine announcement with no forward-looking information; stock may be driven by broader market sentiment.
Market Snapshot
Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
95% bullish (20 analysts)
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3283681 |
12 reports for TSHA
100% Hit rate best @ T+60▲ +20.50%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 11, 2026 7w ago | Press Release | $6.41 $5.16 | ▼ −19.44% | ▼ −17.54% | $4.66 (−27.17%) |
Jun 25, 2026 14w ago | 8-K | $6.34 $5.83 | ▼ −8.04% | ▼ −9.30% | $4.66 (−26.42%) |
Jun 25, 2026 14w ago | 424B5 | $6.34 $5.83 | ▲ +8.04% | ▲ +9.30% | $4.66 (+26.42%) |
Jun 25, 2026 14w ago | Press Release | $6.21 $5.83 | ▲ +6.12% | ▲ +6.65% | $4.66 (+24.88%) |
Jun 5, 2026 17w ago | Press Release | $5.50 $6.38 | ▲ +16.00% | ▲ +14.14% | $4.66 (−15.18%) |
May 6, 2026 21w ago | 8-K | $6.98 $5.55 | ▼ −20.49% | ▼ −23.27% | $4.66 (−33.17%) |
May 6, 2026 21w ago | Press Release | $6.98 $5.55 | ▼ −20.49% | ▼ −23.27% | $4.66 (−33.17%) |
Apr 29, 2026 22w ago | Press Release | $6.27 $5.75 | ▼ −8.29% | ▼ −13.75% | $4.66 (−25.60%) |
Apr 27, 2026 22w ago | Press Release | $6.30 $5.59 | ▼ −11.27% | ▼ −16.74% | $4.66 (−25.95%) |
Apr 22, 2026 23w ago | DEFA14A | $6.72 $5.19 | ▼ −22.84% | ▼ −26.01% | $4.66 (−30.58%) |
Showing 10 of 12
US Market Status
Market Open — Closes in 48m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access